Abstract: Owing to the rapid progress in artificial intelligence (AI) and the widespread use of generative learning, the problem of sparse data has been solved effectively in various research fields.
SHINee’s Key has spent nearly two decades refining his artistry, and he wants to leave no room for misinterpretation: His achievements are all thanks to his own blood, sweat and tears. While casual ...
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first ...
Prime Minister Narendra Modi on Thursday left for home after concluding a “substantive” visit to Oman, during which the two nations inked a milestone free trade agreement. Modi was seen off by Sayyid ...
Americans will be able to save more for retirement in 2026, and the changes go well beyond a routine cost-of-living adjustment. New IRS contribution limits, combined with a major shift in the rules ...
The Versius Plus surgical robotics system [Image courtesy of CMR Surgical] CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance. Versius ...
Enhanced wearable builds on Revi’s strong clinical evidence, meaningful symptom relief, and exceptionally high patient satisfaction. SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader ...
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (HSCS) (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information ...
During Black Friday, Dell lowered the price of its venerable 34" Alienware AW3423DWF QD-OLED gaming monitor from $900 to just $499.99 shipped. That was a new historical price low, but today there's a ...
ROCK HILL, S.C., Dec. 15, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE: DDD) today announced that the U.S. Food and Drug Administration has granted 510(k) clearance expanding the indications for its VSP ...
Dr. Vinay Prasad, the FDA's director of the Center for Biologics Evaluation and Research, is said to be making plans to unveil by the end of this year a plan to include the most serious warnings on ...
The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the first therapy of its kind for the rare disease and making Italy’s Fondazione ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback